drugset / Trial / NCT02174523
Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects
Phase 1
Completed
14 enrolled
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Xuhui Central Hospital, Shanghai · collab
RandomizedParallel-groupTriple-blindOther
Summary
To evaluate the pharmacokinetic (PK) characteristics after multiple oral administration of 40 mg lurasidone in healthy Chinese subjects. To evaluate the safety and tolerance after multiple oral administration of 40 mg lurasidone in healthy Chinese subjects.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 40 mg | Oral |